Build MedTech Products That Pay Off – Clinically And Economically

We combine end‑to‑end product development with payer‑grade health economics, so you don’t have to juggle dev shops, consultants, and reimbursement experts on your own.

Book a call

One Team that Understands Code, Clinics, and Cashflows

We help MedTech and digital health founders build products that work in real clinical settings and make economic sense.

By combining ULAM LABS’ software and product team with Zeumed’s health economics and reimbursement expertise, you move faster from concept to sustainable revenue instead of iterating blindly.



What You Get

Outcomes you can expect:

Reduce build risk

Validate what to build, for whom, and in which care pathway before you commit to a full MVP or expensive clinical integrations.

Design for reimbursement from day one

Align features, data, and evidence with payer expectations early, so you’re not retrofitting your product to fit reimbursement codes later.

Accelerate market entry and scale

Use one integrated product, engineering, and health‑economics team instead of stitching together agencies, consultants, and dev shops on your own.

Strengthen your fundraising story

Turn your clinical promise into a clear economic narrative, pricing strategy, and adoption roadmap that investors can underwrite

Is It You?

Book a call
Building MedTech or digital health solutions (software, data platforms, decision‑support tools, or connected devices)
Moving from pre‑MVP to first pilots, or from pilots to repeatable, reimbursed revenue.
Preparing for pre‑seed to Series A/B rounds and need a credible evidence and economics story alongside a robust product.

How It Works?

Discovery call

Clarify your clinical problem, target users, payer landscape, and funding timeline in one session.

Integrated product
and economics plan

You receive a concrete plan covering product scope, technical approach, evidence and data strategy, and pricing/reimbursement options.

Build, test, and evidence

ULAM Labs builds and tests your product while Zeumed shapes the economic model, evidence plan, and payer‑ready value story.

Launch, iterate, and support fundraising

We support you through pilots, payer and provider conversations, and investor meetings with the product, metrics, and narrative aligned.

Book a call

Why Us?

One team that understands code, clinics, and cashflows.

1ULAM LABS

Specialized in compliant MedTech product custom software with a focus on security and regulatory requirements.

2Zeumed

Health economics and policy advisory translating complex payer requirements into practical pricing, reimbursement, and value strategies for digital health and medtech.

Plan Your Path To Reimbursement

Book a free call and learn how we can proceed!

Book a call

Blog

Read about software development on our blog

As industry experts, we share our knowledge on the blog to help you navigate through MedTech product development and assist you with developing your projects.

Read Expert Insights

FAQ

This service is designed for medtech and digital health startups from pre‑MVP to Series A/B that need both robust software and a credible economic case. Founders, CEOs, CTOs and C‑level leaders who must convince clinicians, payers and investors will get the most value.

We can either lead end‑to‑end product development or collaborate with your existing team. In the second model, we focus on architecture, critical workflows and making sure product decisions align with evidence, pricing and reimbursement strategy.

    You get one integrated team with a single point of contact. Product, engineering and health‑economics experts join the same workshops and planning sessions, so technical scope, clinical value and economic logic are aligned from day one.

    Yes. We often start with teams that have a defined problem and target users, but are still shaping the exact product. We help validate use cases, map data and workflow requirements, and identify where payers and providers are most likely to see value.

    We translate the product and economics work into clear decks, narratives and metrics that investors understand. This may include market sizing, value‑based pricing logic, unit economics assumptions and adoption scenarios you can confidently discuss in meetings.